Related Experiment Video
Updated: May 26, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Small interfering RNA against transcription factor STAT6 leads to increased cholesterol synthesis in lung cancer cell
Richa Dubey1, Ravindresh Chhabra, Neeru Saini
1Functional Genomics Unit, Institute of Genomics and Integrative Biology (CSIR), Delhi, India.
Abstract:
STAT6 transcription factor has become a potential molecule for therapeutic intervention because it regulates broad range of cellular processes in a large variety of cell types. Although some target genes and interacting partners of STAT6 have been identified, its exact mechanism of action needs to be elucidated. In this study, we sought to further characterize the molecular interactions, networks, and functions of STAT6 by profiling the mRNA expression of STAT6 silenced human lung cells (NCI-H460) using microarrays. Our analysis revealed 273 differentially expressed genes after STAT6 silencing. Analysis of the gene expression data with Ingenuity Pathway Analysis (IPA) software revealed Gene expression, Cell death, Lipid metabolism as the functions associated with highest rated network. Cholesterol biosynthesis was among the most enriched pathways in IPA as well as in PANTHER analysis. These results have been validated by real-time PCR and cholesterol assay using scrambled siRNA as a negative control. Similar findings were also observed with human type II pulmonary alveolar epithelial cells, A549. In the present study we have, for the first time, shown the inverse relationship of STAT6 with the cholesterol biosynthesis in lung cancer cells. The present findings are potentially significant to advance the understanding and design of therapeutics for the pathological conditions where both STAT6 and cholesterol biosynthesis are implicated viz. asthma, atherosclerosis etc.
Insights
STAT6 transcription factor silencing inversely affects cholesterol biosynthesis in lung cancer cells. This finding reveals a novel therapeutic target for conditions involving both STAT6 and cholesterol metabolism.
Area of Science:
- Molecular Biology
- Cell Biology
- Genomics
Background:
- STAT6 (Signal Transducer and Activator of Transcription 6) is a transcription factor regulating diverse cellular processes.
- Its precise molecular mechanisms and interactions remain incompletely understood.
- STAT6 is a potential therapeutic target in various cell types.
Purpose of the Study:
- To elucidate the molecular interactions, networks, and functions of STAT6.
- To characterize the impact of STAT6 on gene expression in human lung cancer cells.
Main Methods:
- Microarray analysis of STAT6-silenced human lung cells (NCI-H460).
- Ingenuity Pathway Analysis (IPA) and PANTHER for pathway enrichment.
- Validation using real-time PCR and cholesterol assays.
- Experiments conducted on A549 lung cells as well.
Main Results:
- STAT6 silencing led to 273 differentially expressed genes.
- IPA identified Gene expression, Cell death, and Lipid metabolism as key associated functions.
- Cholesterol biosynthesis was a significantly enriched pathway.
- An inverse relationship between STAT6 and cholesterol biosynthesis was observed.
Conclusions:
- This study demonstrates, for the first time, an inverse correlation between STAT6 and cholesterol biosynthesis in lung cancer cells.
- These findings offer insights into STAT6 function and its role in lipid metabolism.
- The results have implications for developing therapeutics for diseases like asthma and atherosclerosis.
More Related Videos
Related Concept Videos
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Splicing
Inheritance of Chromatin Structures
The JAK-STAT Signaling Pathway
MicroRNAs

